INTRODUCTION
============

Halitosis, also known as bad breath or malodour, is a condition caused by fetid odours present in air emanating from the mouth[@B1], leading to personal and social discomfort[@B21]. The origin of pathological halitosis can be systemic or local[@B14] and should be diagnosed and treated[@B1] ^,^ [@B14] ^,^ [@B21]. This condition is multifactorial and may comprise both oral and non-oral causes[@B21] ^,^ [@B25]. Periodontal disease, peri-implantitis, deep carious lesions, tongue coating, impacted food or debris, unclean dentures, and other oral problems may contribute to the onset of halitosis[@B9].

Oral bad breath can result from the degradation of proteins containing sulphur amino acids (methionine and cysteine), resulting in the production of volatile sulphur compounds (VSCs), represented by hydrogen sulfide (H~2~S), methyl mercaptan (CH~3~SH), and dimethyl sulphide \[(CH~3~)~2~S\]: gases that emanate malodour[@B1]. Some anaerobic gram-negative bacteria present in the oral cavity, such as *Porphyromonas gingivalis, Fusobacterium nucleatum*, *Prevotella intermedia*, *Tannerella forsythia*, and *Porphyromonas endodontalis,* are the main species responsible for the production of VSCs[@B18]. In addition to the role of VSCs in generating halitosis, there is evidence suggesting that these gases are also involved in the pathogenesis of periodontal diseases[@B1] ^,^ [@B29].

Various oral approaches have been employed to treat halitosis, including the mechanical removal of tongue and subgingival biofilms, the use of chlorhexidine, cetylpyridinium, or essential oil mouthrinses, and the application of masking products such as chewing gums and mouthrinses containing chlorine dioxide and zinc salts[@B5] ^,^ [@B10] ^,^ [@B23] ^,^ [@B26]. It has also been reported that natural products, such as green tea, produce effects that control halitosis and VSC production[@B12] ^,^ [@B28] ^,^ [@B30]. Most products used to reduce malodour have antimicrobial properties, and the decrease in VSCs is usually related to the suppression of bacterial growth.

*Melaleuca alternifolia,* also known as tea tree oil, has been studied because of its antimicrobial activity against oral pathogens, showing inhibitory and bactericidal effects[@B3] ^,^ [@B7] ^,^ [@B8]. A solution containing tea tree oil was shown to reduce the levels of malodour and production of VSCs in patients nursed in an intensive care unit[@B10]. Despite the antimicrobial potential of *M. alternifolia*, there are few studies evaluating its activity against oral pathogens that cause bad breath[@B4] ^,^ [@B8]. Thus, the aim of this study was to evaluate the effects of *Melaleuca alternifolia* oil and chlorhexidine on the viability and VSC production of *P. gingivalis* and *P. endodontalis*.

MATERIAL AND METHODS
====================

Substances tested
-----------------

This study used the essential oil of *Melaleuca alternifolia* (Arista Industries; Wilton, Connecticut, USA) as the tested substance and chlorhexidine gluconate (Sigma-Aldrich; St. Louis, Missouri, USA) as the standard antimicrobial.

Determination of the chemical profile of *M. alternifolia* essential oil by gas chromatography-mass spectrometry (GC-MS)
------------------------------------------------------------------------------------------------------------------------

The essential oil was subjected to gas chromatography analyses to obtain its chemical profile. Analyses were performed on a gas chromatograph, model: HP-6890 (HP; Palo Alto, California, USA), interfaced with a mass selective detector HP-5975. A fused silica capillary column HP-5 (length of 30 m, internal diameter of 0.25 mm and film thickness of 0.25 mµ) was used with helium as the carrier gas (1 mL min^-1^).

The oil was diluted with ethyl acetate, and 0.1 mL was injected into the device. The temperatures used were 220°C for the injector, 250°C for the detector, and 60°C -- 240°C for the column (3°C min^-1^). To identify the analytes, a mixture of n-alkanes was used to calculate the retention index (RI). Comparisons were performed using the National Institute of Standards and Technology (NIST) electronic library and literature data based on RI. The determination of essential oil components was based on the calculation of the area under the peaks.

Bacterial strains and culture conditions
----------------------------------------

*P. gingivalis* W83 and *P. endodontalis* (isolated from clinical sample) were cultivated in Tryptic Soy Broth (TSB -- Difco Co.; Detroit, Michigan, USA) or TSA (Tryptic Soy Agar - Difco Co.; Detroit, Michigan, USA), both supplemented with hemin (5 µg/mL), menadione (1 µg/mL), and 2% of Yeast Extract (Difco Co.; Detroit, Michigan, USA). Growth and cultivation were performed under anaerobic conditions (10% CO~2~, 10% H~2,~ and 80% N~2~) using an anaerobic chamber (MiniMacs Anaerobic Workstation - Don Whitley Scientific; Shipley, West Yorkshire UK) at 37°C.

Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC)
-----------------------------------------------------------------------------------

MIC and MBC were carried out according to Clinical and Laboratory Standards Institute (CLSI)[@B5] with some modifications. For the determination of MIC and MBC, serial two-fold dilutions were made for all substances tested. Concentrations ranged from 0.5% (v/v) to 0.002% (v/v) for the essential oil of *M. alternifolia* and from 100 µg/mL (0.01% -- p/v) to 0.38 µg/mL (0.0038% -- p/v) for the chlorhexidine solution. An inoculum of 40% transmittance, equivalent to approximately 8x10[@B8] CFU/mL, was prepared from bacterial cultures on TSA with three days of growth, and 500 µL samples of this bacterial suspension were transferred to tubes containing the test substances in a final volume of 6 mL. Moreover, tubes without tested compounds or bacterial suspension were used as controls. Cultures were maintained under anaerobic conditions for 48 hours. The lowest concentration of each substance with no bacterial growth was considered the MIC. For MBC determination, 10 µL samples from TSB cultures were transferred to TSA plates and incubated for five days under anaerobic conditions. The lowest concentration with no bacterial growth was considered the MBC.

*In vitro* production of Volatile Sulphur Compounds (VSCs)
----------------------------------------------------------

Sub-MIC concentrations of *M. alternifolia* oil and chlorhexidine were tested to evaluate their effects on VSC production and to ensure bacterial growth and gas production. Thus, concentrations tested were as follows: 0.002%, 0.001%, and 0.0005% for *M. alternifolia*; 0.38 µg/mL (0.0038%), 0.19 µg/mL (0.0019%), 0.095 µg/mL (0.00095%), and 0.048 µg/mL (0.00048%) for chlorhexidine digluconate; representing concentrations 4, 8, and 16 times smaller than the MIC (4x \<MIC, 8x \<MIC, 16x \<MIC).

The inoculum was prepared as described in item 2.3. To collect gas from inside the tubes, needles (Becton Dickinson Company; Franklin Lakes, New Jersey, USA) were coupled with the covers of the tubes. After 16 hours of growth in anaerobic conditions, 1 mL syringes were attached to the needles, and 0.1 mL of air was aspirated from inside each tube. The volume of air collected was injected into the OralChroma™ (CHM-1, Abilit Corporation; Chuo-ku, Osaka, Japan). After measurement, the device provided the concentrations of hydrogen sulfite (H~2~S), methylmercaptan (CH~3~SH), and dimethylsulfide \[(CH~3~)~2~S\] in parts *per* billion. The tubes were also subjected to absorbance readings (λ=660 nm) in a Unico 1100 RS spectrophotometer (Unico Inc; Dayton, New Jersey, USA).

Statistical analysis
--------------------

All experiments were performed in eight replicates and reproduced at least two times. The Lilliefors test (an adaptation of the Kolmogorov-Smirnoff test) was used to check the normality of data distribution. For VSC data, analysis of variance (ANOVA) was performed, and the difference among groups was verified by Tukey test, using the BioEstat software (version 5.0 -- AnalystSoft Inc./CNPQ; Belém, Pará, Brazil). The significance level was set at 5%.

RESULTS
=======

Chemical profile of the essential oil of *M. alternifolia*
----------------------------------------------------------

The characterization of essential oil compounds was performed by comparing retention times and MS/MS mass spectra of each peak with information in the NIST library. The compounds identified and the percentage range for tea tree oil recommended by ISO 4730:2004 are described in [Table 1](#t1){ref-type="table"}.

Table 1Identification of analytes of *M. alternifolia* essential oil compared with the standard composition recommended by ISO 4730; a) TR -- peak retention time (in minutes); b) fraction in percent of total integrated area for the chromatogramt~R~ (min) ^(a)^Analytes identifiedRelative % ^(b)^% recommended (ISO 4730:2004)4.66alpha-thujene0.72\-\--4.84alpha-pinene1.981.0-6.05.87beta-pinene0.51\-\--6.23beta-myrcene0.59\-\--6.63alpha-phellandrene0.35\-\--7.06alpha-terpinene9.130.5-137.27p-cymene2.490.5-127.471,8-cineole (Eucalyptol)3.42≤ 158.5gamma-terpinene19.7210-289.41terpinolene3.031.5-5.013.2terpinen-4-ol42.07≥ 3013.52alpha-terpineol2.881.5-8.022.19alpha-gurjunene0.39\-\--22.58trans-caryophyllene0.36\-\--23.39aromadendrene1.33Trace-7.024.24alloaromadendrene0.58\-\--25.48cis-beta-guaiene0.17\-\--25.85alpha-muurolene0.14\-\--26.79delta-cadinene1.61Trace-8.027.09cadina-1,4-diene0.19\-\--29.33viridiflorol0.18Trace- 1.529.43cubeban-11-ol0.16\-\--30.71-epi-cubenol0.21\-\--59.58squalene5.24\-\--

Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC)
-----------------------------------------------------------------------------------

The MIC and MBC values for *M. alternifolia* oil and chlorhexidine solution are shown in [Table 2](#t2){ref-type="table"}. The tea tree oil and chlorhexidine digluconate solution were able to inhibit the growth of both strains at low concentrations.

Table 2Values of MIC and MBC for *M. alternifolia* essential oil and for the chlorhexidine digluconate solutionBacterial Strains*M. alternifolia*Chlorhexidine*M. alternifolia*Chlorhexidine*P. gingivalis* W830.007 %1.5 µg/ml (0.00015 %)0.007 %1.5 µg/ml (0.00015 %)*P. endodontalis*0.007 %1.5 µg/ml (0.00015 %)0.5 %1.5 µg/ml (0.00015 %)

*In vitro* production of Volatile Sulphur Compounds
---------------------------------------------------

The effects of sub-MIC concentrations of tea tree oil and chlorhexidine on the growth and production of volatile sulphur gases (H~2~S and CH~3~SH) are shown in figures [1](#f01){ref-type="fig"} and [2](#f02){ref-type="fig"} for *P. gingivalis* W83, and in Figures [3](#f03){ref-type="fig"} and [4](#f04){ref-type="fig"} for *P. endodontalis*. Concentrations tested were lower than the minimum inhibitory concentration (sub-MIC concentrations) and were defined in previous tests.

Figure 1Effects of sub-MIC concentrations of tea tree oil on growth (D.O. -- 660 nm) and production of volatile sulphur gases (H2S and CH3SH) for *P. gingivalis* W83. Significant differences among treatments and the control group were considered when p\<0.05 (ANOVA, Tukey test). Different letters represent differences among groups

Figure 2Effects of sub-MIC concentrations of chlorhexidine on growth (D.O. -- 660 nm) and production of volatile sulphur gases (H2S and CH3SH) for *P. gingivalis* W83. Significant differences among treatments and the control group were considered when p\<0.05 (ANOVA, Tukey test). Different letters represent differences among groups

Figure 3Effects of sub-MIC concentrations of tea tree oil on growth (D.O. -- 660 nm) and production of volatile sulphur gases (H2S and CH3SH) for *P. endodontalis*. Significant differences among treatments and the control group were considered when p\<0.05 (ANOVA, Tukey test). Different letters represent differences among groups

Figure 4Effects of sub-MIC concentrations of chlorhexidine on growth (D.O. -- 660 nm) and production of volatile sulphur gases (H2S and CH3SH) for *P. endodontalis*. Significant differences among treatments and the control group were considered when p\<0.05 (ANOVA, Tukey test). Different letters represent differences among groups

The tea tree oil reduced the growth of *P. gingivalis* W83 and significantly changed the production of CH~3~SH at all concentrations tested (16x\<MIC, 8x\<MIC, and 4x\<MIC). Curiously, the 16x\<MIC concentration promoted less CH~3~SH production than higher concentrations (p\<0.05). The production of H~2~S was not altered by the essential oil at any of the concentrations. In the presence of chlorhexidine, *P. gingivalis* W83 showed a reduction in growth at concentrations of 8x\<MIC and 4x\<MIC, and they were different from each other (p\<0.05). Furthermore, it exhibited a reduction in CH~3~SH levels for all concentrations tested and in H~2~S for 8x\<MIC and 4x\<MIC (p\<0.05).

The microorganism *P. endodontalis* showed a reduction in growth in the presence of tea tree oil for concentrations 8x\<MIC and 4x\<MIC (p\<0.05). Decreased gas production was observed for both H~2~S (16x\<MIC, 8x\<MIC, and 4x\<MIC) and CH~3~SH (8x\<MIC and 4x\<MIC) (p\<0.05). However, at the concentrations tested, chlorhexidine showed effects on *P. endodontalis* growth (p\<0.05) but not on VSC production.

DISCUSSION
==========

As a result of the significant contribution of VSCs to halitosis development, many studies involving therapies for the treatment of halitosis have focused on the inhibition and reduction of VSC production. Antimicrobial therapy aims to enhance mechanical treatments and support host defences, reducing the development of microorganisms. Some studies have demonstrated the efficacy of *M. alternifolia* against oral bacteria[@B7] ^,^ [@B8] ^,^ [@B11] ^,^ [@B24]; however, little is known about its effects on VSC production. Here, we showed that *M. alternifolia* essential oil can reduce growth and VSC levels of *P. gingivalis* and *P. endodontalis*, even at sub-MIC concentrations.

GC-MS analysis of the tea tree oil used in this study showed that the composition of this oil was consistent with the International Standard ISO 4730:2004, which specifies certain characteristics of *M. alternifolia* oil such as quality requirements. The main components described by the ISO for *M. alternifolia* oil are terpinen-4-ol, γ-terpinene, α-terpinene, 1,8-cineole, p-cymene, α-terpineol, α-pinene, terpinolene, limonene, and sabinene[@B20]. All of these compounds were found in the oil used in this study, except for limonene and sabinene. However, these two compounds are generally found in small quantities in tea tree oil (0.5% - 4% and trace -- 3.5%, respectively), and their low levels may be the reason they were not identified by CG-MS analysis. In contrast, terpinen-4-ol and α-terpineol, which are substances with antimicrobial activity, were found in satisfactory percentages[@B4] ^,^ [@B13]. *M. alternifolia* have a mixture of components and their mechanisms of action are not completed elucidated. It is known that the combination of these different substances in the tea tree oil are capable of inducing loss of intracellular material, inhibition of respiration, and alterations in the homeostasis, leading to loss of bacterial membrane integrity and function[@B4].

The tea tree oil showed antimicrobial activity: its MIC value was 0.007% for both bacteria, and MBC values were 0.5% for *P. endodontalis* and 0.007% for *P. gingivalis*. In a previous study, the MIC value found for *P. gingivalis* was 0.13% - 0.25%, and the MBC value was 0.13% - 0.5%[@B22]. Although MIC values differed between studies, MBC values were similar. Differences in MIC values may be due to different strains tested: in this study we used the W83 strain, while Takarada, et al.[@B22] (2004) used the ATCC 33277, 53977, Su63, and W50 strains. To the best of our knowledge, there are no previous studies in the literature showing the effects of *M. alternifolia* on *P. endodontalis*.

To evaluate the activity of *M. alternifolia* and chlorhexidine on the production of volatile sulphur compounds, sub-inhibitory concentrations of these substances were used. The sub-MIC concentrations of the tea tree oil affected the growth of both microorganisms, reducing the growth at higher concentrations (8x\<, 4x\<MIC, and 16x\<MIC). Furthermore, at all concentrations tested, tea tree oil reduced CH~3~SH production in *P. gingivalis* and both H~2~S and CH~3~SH production in *P. endodontalis*. As not expected, the 16x\<MIC concentration promoted a higher reduction of CH~3~SH than the 8x\< and 4x\<MIC concentrations. We believe that higher concentrations of tea tree oil (8x and 4x\<MIC) could stress the bacteria and stimulate a little the VSC production comparing to the lower concentrations (16x\<MIC). However, this hypothesis has to be confirmed.

The CH~3~SH and H~2~S gases are the main VSCs in intra-oral halitosis[@B1], and their toxicity is associated with the development of periodontal disease[@B15] ^,^ [@B16] ^,^ [@B29]. Tea tree oil was able to inhibit the growth of *P. gingivalis* W83 and *P. endodontalis*, and the production of VSCs. Thus, this essential oil is a promising substance for treating halitosis. Previously, *M. alternifolia* oil was found to be effective as one of the components of an antiseptic mouth rinse[@B10]. In addition, α-terpineol, one of the compounds present in tea tree oil and identified in our study, has demonstrated activity against a number of oral pathogens involved in periodontal disease and caries[@B17].

Chlorhexidine is widely used in mouthrinses, causing membrane disruption and inhibition of proteolytic and glycosidic enzimes, leading to growth inhibition and cell death[@B27]. Despite being a potent antimicrobial, it has certain side effects such as altered taste, mucosal desquamation, tooth staining, increased calcified supra-gingival deposits, and a burning sensation in the oral mucosa[@B19]. Compared with chlorhexidine, tea tree oil showed similar antimicrobial activity, promoting bactericidal and bacteriostatic effects at low concentrations. Thus, tea tree oil could be a good alternative to chlorhexidine in oral hygiene products, mainly mouthrinses. Therefore, the development of new mouthrinses containing tea tree oil and clinical studies testing these products are necessary.

In conclusion, *M. alternifolia* oil showed antimicrobial activity against *P. gingivalis* W83 and *P. endodontalis*, reducing the growth and the production of VSCs at sub-MIC concentrations, comparably to chlorhexidine. Future studies can be conducted focusing on the development of pharmaceutical products containing *M. alternifolia* oil for halitosis treatment.
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